Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial.

We observed a decreasing trend in leptin and CRP levels, an increasing trend for SHGB (Supplementary Table 2), and a significant positive correlation between MKI67 expression and TNFα and resistin (Supplementary Fig. 1d).

also in 47,180 other papers